retatrutide nejm This week's most cited articles: 1. Original Article: Triple–Hormone-Receptor Agonist for Obesity — A Phase 2 Trial https://t.co/jNL1GNnHPT #Endocrinology Retatrutide 10 mg: vial guide
Description
Semaglutide once weekly as add-on to SGLT-2 inhibitor therapy in type 2 diabetes (SUSTAIN 9): A randomised, placebo-controlled trial
This improvement was accompanied by a significant reduction in high-sensitivity CRP concentration, suggesting that the antiinflammatory effects of GLP-1 medicines may contribute to or be independently associated with their benefits in OSA
Heart rate variability in obesity and the effect of weight loss
OPTAVIA provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life
